Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity represents a long non-coding RNA (lncRNA) that is transcribed in the sense (coding) direction within an intron of the gene CTIF (Cap-binding complex-dependent translation initiation factor). It has only been annotated based on high-throughput transcriptomic data, without experimental validation for protein-coding potential, cellular function, or disease association. Such lncRNAs are often computationally discovered, and while they add to the landscape of human transcriptomics, their roles remain speculative until further research confirms function, clinical relevance, or therapeutic applicability.\nENSG00000300561 is a computationally-predicted lncRNA, not an established molecular target like a receptor, enzyme, or transporter. It does not have drug interactions, mechanisms, or recognized biological/disease roles. Its annotation is preliminary, and the entry is likely inappropriate for structured drug discovery or therapeutic targeting.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to CTIF (ENSG00000300561).